Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2Gynecologic 2Gastrointestinal 2Breast 2Thoracic 1

Conditions

Rectal Neoplasms 1Colonic Polyps 1Colonic Neoplasms 1

Interventions

Oxaliplatin 1413Fluorouracil 1301Capecitabine 1087Gemcitabine 1045Leucovorin 932Irinotecan 818Bevacizumab 804Cisplatin 669Radiotherapy 536Cetuximab 470pembrolizumab 428Paclitaxel 390Nivolumab 337130-nm albumin-bound paclitaxel 325Drug Therapy 314Docetaxel 287S 1 (combination) 274Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 210Surgical Procedures, Operative 204tislelizumab 203Radiosurgery 202lenvatinib 201apatinib 200Carboplatin 187Magnetic Resonance Spectroscopy 183regorafenib 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Iohexol × Gastrointestinal × Clear all
NCT00576563 2016-04-21

Rectal Study: Value of Repeated FDG-PET-CT Scans in Rectal Cancer

Maastricht Radiation Oncology

Phase NA Completed
103 enrolled
Gastrointestinal

Rectal Neoplasms

NCT01200303 2015-08-05

ncCTC

Massachusetts General Hospital

Phase 2/3 Completed
605 enrolled
Gastrointestinal

Colonic Neoplasms, Colonic Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡